Regencell Bioscience Holdings (Regencell Bioscience Holdings) Short-Term Capital Lease Obligation : $0.44 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Short-Term Capital Lease Obligation?

Regencell Bioscience Holdings's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.44 Mil.

Regencell Bioscience Holdings's quarterly Short-Term Capital Lease Obligation declined from Jun. 2022 ($0.41 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Jun. 2023 ($0.44 Mil).

Regencell Bioscience Holdings's annual Short-Term Capital Lease Obligation increased from Jun. 2021 ($0.00 Mil) to Jun. 2022 ($0.41 Mil) and increased from Jun. 2022 ($0.41 Mil) to Jun. 2023 ($0.44 Mil).

Regencell Bioscience Holdings Short-Term Capital Lease Obligation Historical Data

The historical data trend for Regencell Bioscience Holdings's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Short-Term Capital Lease Obligation Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

0.41

0.44

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial				-	-	0.41	-	0.44

Regencell Bioscience Holdings Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Regencell Bioscience Holdings Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.